PFE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

PFEPfizer Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

PFEPfizer Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

PFEwithLLY

×0.64co-movement · LLY on PFE · 500d

r 0.40scale to r 0.75

Shared co-movers7with PFEwith LLY

MRKMerck & Co., Inc.r 0.58r 0.42

AMGNAmgen Incr 0.58r 0.41

BIIBBiogen Inc.r 0.54r 0.40

NVSNovartis AGr 0.53r 0.39

GSKGSK plcr 0.53r 0.37

ABBVAbbVie Inc.r 0.49r 0.37

PFE, solidLLY, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

PFEPfizer Inc

29.88▼−1.52%· post 29.89

Mkt cap$167.9BRevenue$16.6BQ3 FY26Revenue$62.6BFY25

LLYELI Lilly & Co

1,371.32▼−3.29%· post 1,363.77

ClosedNov 5 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 5 '26

PFEPfizer Inc

LLYELI Lilly & Co

29.88▼−1.52%post 29.89

Price

1,371.32▼−3.29%post 1,363.77

$167.9B

Mkt cap

$1.2T

Q3 FY26$16.6B

Revenue

$24.4BQ3 FY26

FY25$62.6B

Revenue

$65.2BFY25

PFE29.88▼−1.52%vsLLY1,371.32▼−3.29%ClosedNov 5 '26